Pricing Log in Create free account

Kiora Pharmaceuticals, Inc. (KPRX) vs Synlogic, Inc. (SYBX)

Kiora Pharmaceuticals, Inc. and Synlogic, Inc. are both Biotechnology companies. Kiora Pharmaceuticals, Inc. and Synlogic, Inc. are of similar size ($6.7M and $6.6M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against 188.7%. Across the 14 metrics below, Synlogic, Inc. leads on 8 and Kiora Pharmaceuticals, Inc. on 6.

Valuation

Metric KPRX SYBX Biotechnology median
P/E n/m n/m 10.60
P/S 0.47 4.26 9.40
P/B 0.52 1.14 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.62 n/m 0.66
EV/Sales (0.42) 0.15 9.02
Earnings yield (174.20%) (5.45%) (32.88%)
Free cash flow yield (98.19%) (26.92%) (23.13%)

Profitability

Metric KPRX SYBX Biotechnology median
Gross margin 85.06% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.36%) (5.32%) (51.96%)
Return on assets (39.43%) (4.25%) (46.06%)
Return on invested capital (44,053.91%) 0.00% 0.00%

Growth

Metric KPRX SYBX Biotechnology median
Revenue growth (TTM) 983.73% 188.74% 6.76%
EPS growth (last fiscal year) (403.45%) 95.83% 29.88%
Revenue growth, 5-year CAGR 88.72% (67.55%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPRX SYBX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.97 9.19 4.97
Net debt to EBITDA 1.33 3.66 1.01

Dividend

Metric KPRX SYBX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KPRX SYBX Biotechnology median
Market cap 6.63m 6.68m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack